Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

What to advise patients about drinking alcohol. The clinician's conundrum.

Pearson TA, Terry P.

JAMA. 1994 Sep 28;272(12):967-8. No abstract available.

PMID:
7794309
2.

Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator.

Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ, Hennekens CH.

JAMA. 1994 Sep 28;272(12):929-33.

PMID:
7794308
3.

Survey of trends and gaps in dermatologists' cardiovascular screening practices in psoriasis patients: Areas still in need of improvement.

Manalo IF, Gilbert KE, Wu JJ.

J Am Acad Dermatol. 2015 Nov;73(5):872-4.e4. doi: 10.1016/j.jaad.2015.07.029. No abstract available.

PMID:
26475543
4.

Opportunities for deprescribing statins in patients with poor cancer prognosis.

Turner J, Singhal N, Bell JS.

J Palliat Med. 2013 Nov;16(11):1328. doi: 10.1089/jpm.2013.0278. Epub 2013 Sep 20. No abstract available.

PMID:
24053634
5.

A clinician's dilemma: diminished capacity in HIV/AIDS patients.

Carney L, Hopper MJ.

HIV Clin. 2003 Spring;15(2):1, 5-8. No abstract available.

PMID:
12793352
6.

Effects of moderate alcohol consumption on platelet function, tissue-type plasminogen activator and plasminogen activator inhibitor.

Veenstra J, Kluft C, Ockhuizen TH, vd Pol H, Wedel M, Schaafsma G.

Thromb Haemost. 1990 Jun 28;63(3):345-8.

PMID:
2119523
7.

Fibrate use in the United States and Canada.

Tenenbaum A, Fisman EZ.

JAMA. 2011 Jul 13;306(2):157; author reply 158-9. doi: 10.1001/jama.2011.945. No abstract available.

PMID:
21750290
8.

Expanding role for combination drug therapy in the initial treatment of hypertension?

Kotchen TA.

Hypertension. 2011 Oct;58(4):550-1. doi: 10.1161/HYPERTENSIONAHA.111.178939. Epub 2011 Aug 8. No abstract available.

9.

Alcohol and the cardiovascular system: a double-edged sword.

Katsiki N, Tziomalos K, Mikhailidis DP.

Curr Pharm Des. 2014;20(40):6276-88. Review.

PMID:
24953395
10.

[Transferring to the practice the results of the clinical trials with statins: from the relative risk to the absolute risk].

Martín-Luján F, Baldrich-Justel M, Bejarano-Romero F.

Med Clin (Barc). 2005 Dec 3;125(20):799. Spanish. No abstract available.

PMID:
16373038
11.

Fibrate use in the United States and Canada.

Lim LS, Wong TY.

JAMA. 2011 Jul 13;306(2):157-8; author reply 158-9. doi: 10.1001/jama.2011.946. No abstract available.

PMID:
21750289
12.

HEDIS, beta-blockers, and what more can be done to improve secondary prevention in ACS.

Curtiss FR.

J Manag Care Pharm. 2008 Apr;14(3):316-7. No abstract available.

13.

Regular alcohol intake and fibrinolysis.

van Golde PM, Hart HCh, Kraaijenhagen RJ, Bouma BN, van de Wiel A.

Neth J Med. 2002 Aug;60(7):285-8.

14.

Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort.

Mukamal KJ, Jadhav PP, D'Agostino RB, Massaro JM, Mittleman MA, Lipinska I, Sutherland PA, Matheney T, Levy D, Wilson PW, Ellison RC, Silbershatz H, Muller JE, Tofler GH.

Circulation. 2001 Sep 18;104(12):1367-73.

15.
16.

Combination therapy to prevent cardiovascular disease: slow progress.

Smith R, McCready T, Yusuf S.

JAMA. 2013 Apr 17;309(15):1595-6. doi: 10.1001/jama.2013.3180. No abstract available.

PMID:
23529576
17.

Physicians' prescription for lifetime abstainers aged 40 to 50 to take a drink a day is not yet justified.

Greenfield TK, Kerr WC.

Alcohol Clin Exp Res. 2014 Dec;38(12):2893-5. doi: 10.1111/acer.12582. No abstract available.

18.

Alcohol and health: a drink a day won't keep the doctor away.

Lieber CS.

Cleve Clin J Med. 2003 Nov;70(11):945-6, 948, 951-3.

PMID:
14650469
19.

The effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels are dependent on environmental context.

Asselbergs FW, Williams SM, Hebert PR, Coffey CS, Hillege HL, Snieder H, Navis G, Vaughan DE, van Gilst WH, Moore JH.

Hum Genet. 2007 Nov;122(3-4):275-81. Epub 2007 Jun 26.

PMID:
17593394
20.

Endogenous tissue-type plasminogen activator and risk of myocardial infarction.

Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH.

Lancet. 1993 May 8;341(8854):1165-8.

PMID:
8098074

Supplemental Content

Support Center